𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nationwide survey of nevoid basal cell carcinoma syndrome in Japan revealing the low frequency of basal cell carcinoma

✍ Scribed by Mamiko Endo; Katsunori Fujii; Katsuo Sugita; Kayoko Saito; Yoichi Kohno; Toshiyuki Miyashita


Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
194 KB
Volume
158A
Category
Article
ISSN
1552-4825

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Nevoid basal cell carcinoma syndrome (NBCCS) is characterized by developmental defects and tumorigenesis. The clinical manifestations of NBCCS have been reported in large epidemiological studies from the United States, the United Kingdom, and Australia, but not from an Asian country. We conducted a nationwide survey and identified 311 NBCCS patients in Japan. We investigated the detailed clinical manifestations of 157 patients ranging in age from 9 months to 77 years old (mean: 33.1 years). We then compared the frequency and age of onset for various tumors developed in Japanese NBCCS patients with patients from the three countries listed above in which NBCCS studies were previously conducted. Our most significant finding was the low frequency of basal cell carcinoma (BCC) in Japanese patients. Frequency of BCC in patients over 20 years of age was 51.4%, a much lower rate compared to the United States, Australia, and the United Kingdom (91%, 85%, and 73%, respectively). The mean age of BCC onset was 37.4 years of age, a much older age compared to the above‐mentioned countries. These findings suggest that differences in ethnicity and/or environmental factors affect the incidence of BCC. Because the age of BCC onset is generally higher in Japanese NBCCS patients, careful skin examination over a prolonged period of time is warranted. Β© 2012 Wiley Periodicals, Inc.


πŸ“œ SIMILAR VOLUMES


De novo mutations of thepatched gene in
✍ Wicking, Carol; Gillies, Susan; Smyth, Ian; Shanley, Susan; Fowles, Lindsay; Rat πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 28 KB πŸ‘ 1 views

The demonstration that mutations in the Patched (PTCH) gene cause nevoid basal cell carcinoma syndrome (NBCCS) has led to the identification of the exact molecular lesion in a percentage of individuals with the syndrome. In addition, it has been possible to determine, through molecular analysis of p

Low levels of urokinase plasminogen acti
✍ T. Maguire; D. Chin; D. Soutar; M.J. Duffy πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 67 KB πŸ‘ 1 views

Basal cell carcinoma of the skin (BCC) is the most common cancer worldwide. Unlike most other human malignancies, BCCs rarely metastasise. In this investigation, we show that the serine protease urokinase plasminogen activator (u-PA), which is causally involved in metastasis, is expressed at lower l